You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藍帆醫療(002382.SZ):藍帆投資及其一致行動人合計持股比例降至28.59%
格隆匯 02-03 19:01

格隆匯 2 月 3日丨藍帆醫療(002382.SZ)公佈,公司的控股股東淄博藍帆投資有限公司(“藍帆投資”)於2020年6月15日發行了藍帆投資2020年非公開發行可交換公司債券(“可交債”)。此次可交債簡稱為“20藍帆E1”,債券代碼為“117164”,發行規模為2億元人民幣,債券期限為3年,換股期限自2020年12月16日起至2023年6月14日止。2021年1月26日至2月1日,藍帆投資可交債持有人換股414.08萬股,藍帆投資及其一致行動人持股數量被動減少。

經中國證券監督管理委員會“證監許可[2020]710號”文核准,公司於2020年5月28日公開發行了3144.04萬張可轉換公司債券(“可轉債”),發行總額314,404萬元。本次可轉債簡稱“藍帆轉債”,債券代碼“128108”,轉股期限自2020年12月3日起至2026年5月27日止,截至2021年2月2日,累計轉股6983.49萬股,公司總股本從9.64億股增加至10.34億股,藍帆投資及其一致行動人李振平的持股比例被動稀釋。

綜合上述原因,藍帆投資及其一致行動人李振平合計持股數量由3.0億股被動減少到2.96億股,合計持股比例由佔2021年1月22日總股本的29.86%減少到佔2021年2月2日總股本的28.59%,被動減持股份比例及持股被動稀釋比例合計超過1%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account